Skip to Main Content

Julian Hong

MD MS

Radiation oncologist

Dr. Julian Hong is a radiation oncologist who specializes in caring for patients with cancers of the genital and urinary organs, including prostate, bladder and kidney cancers. He has particular expertise in advanced techniques that boost precision, including intensity-modulated radiation therapy, image-guided radiation therapy and stereotactic body radiation therapy.

Hong's research centers on developing and exploring the use of computational tools for providing patients with personalized precision treatment. His laboratory uses clinical knowledge and data science techniques to generate insights from real-world data, develop machine learning tools, and study the ways these insights and tools can lead to better patient outcomes. He led one of the first randomized studies demonstrating that machine learning can direct patient care strategies to improve outcomes.

Hong earned his medical degree from the University of Wisconsin School of Medicine and Public Health. He completed a residency in radiation oncology at Duke University Medical Center. He has a master's degree in bioengineering from Stanford University.

Hong serves on NRG Oncology's research committee on cancer care delivery. He is also a member of the American Society for Radiation Oncology's science education and program development subcommittee and the American Medical Informatics Association's summit scientific program committee.

  • Education

    University of Wisconsin School of Medicine and Public Health, MD, 2014

  • Residencies

    Duke University, Radiation Oncology, 2019

  • Academic Title

    Associate Professor

Where I see patients (2)

    My reviews

    5.0

    Overall Experience
    168 Ratings
    About our process
    Dec 18, 2023
    Outstanding interaction with the medical team. Would strongly recommend them.
    Dec 18, 2023
    Dr. Julian Hong is simply the best. He provided and continues to provide excellent health care. His treatment plan proved to be right on. He is friendly, personably and without a doubt my favorite doctor, and I have many.
    Nov 04, 2023
    Of course a great experience
    Oct 23, 2023
    Dr. Hong has always kept me well informed
    Oct 14, 2023
    I always recommend Ucsf as the best in the west. Dr. Hong exemplifies this
    Oct 14, 2023
    Dr. Hung is a great listener. He was sensitive and extremely helpful to me when determining the direction of my care.
    Sep 30, 2023
    Excellent.
    Sep 23, 2023
    Awesome visit.
    Sep 09, 2023
    Dr. Hong was excellent, I couldn't be happier with the care he provided!
    Aug 26, 2023
    Dr Hong meets the highest professional standards
    Aug 19, 2023
    Great
    Aug 19, 2023
    Wonderful experience!
    Aug 14, 2023
    Very pleased with everything
    Jun 17, 2023
    Doctors were very nice to talk to and made us feel comfortable. They were very informative as well
    Jun 13, 2023
    Dr. Hong is just the best. I would refer him without hesitation to a prostate cancer patient.
    Jun 10, 2023
    Best explanations I have ever received
    Apr 22, 2023
    All staff in the cancer practice are absolutely wonderful. This care for patients seems to flow from the very top. Dr. Hong is amazing.
    Apr 14, 2023
    Excellent meeting
    Apr 09, 2023
    I wish all of my care could have been though UCSF. This appointment was one example as to why that is. Best of the best is what I think UCSF and Julian Hong are.
    Apr 08, 2023
    Very helpful. Listened carefully, was very supportive, and gave excellent information.
    Mar 28, 2023
    Very positive experience with care provider.
    Mar 07, 2023
    I have never met a happier, more positive doctor whose bed-side-manner took away any anxiety I had and at the same time was willing to take the extra time needed to explain things in such a way that was understandable to me and would even ask me if I understood it. Phenomenal man and doctor!
    Feb 25, 2023
    Excellent
    Feb 21, 2023
    Dr Hong--EXCELLENT!!!
    Feb 18, 2023
    More then excellent
    Feb 18, 2023
    Dr Hong is very thoughtful and kind
    Feb 04, 2023
    Very good!!
    Dec 23, 2022
    Dr. Hong was very congenial and willing to show me different levels of my PAMA MRI results
    Dec 17, 2022
    Dr. Hong is just fabulous. I could not have selected a better, more professional, and talented physician.
    Dec 03, 2022
    Dr Hong is the BEST!!
    Nov 26, 2022
    Dr. Hong and his staff are on top od everything, I couldn't be happier.
    Oct 10, 2022
    Dr. Hong was exceptional in every single category. Although I don't wish anyone to have to suffer prostate cancer, I would recommend Dr. Hong without reservation.
    Aug 23, 2022
    Dr. Julian Hwang is an amazing individual with a very sweet disposition
    Aug 14, 2022
    This was the first time that a doctor spent as much time as he did with the actual PET scan images pointing out where the cancer was and the various organs in the vicinity.
    Aug 11, 2022
    Dr. Hong has been by my side throughout my journey at UCSF. I always look forward to our chats. Precise, efficient, thorough, smart as all heck, yet engaging, relatable and low key funny. Ask him about Square Pie Guys!
    Jul 26, 2022
    Great discussion
    Decorative Caduceus

    Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intens...

    Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.

    Recruiting

    Decorative Caduceus

    Wearable Activity Tracking to Curb Hospitalizations

    The AUC-ROC of the step count model will measure the performance of a classification model by plotting the rate of true positives against false positives, and the score ranges from 0 - 1. The higher the AUC, the better the model's...

    Recruiting

    Decorative Caduceus

    Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy...

    Kaplan-Meier curves will be generated and metastasis-free survival compared between the two treatment groups by a logrank test, stratified by prostate specific antigen (PSA) level after prostatectomy (never detectable or rising). ...

    Recruiting

    Share